Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
FINDEX Inc. ( (JP:3649) ) just unveiled an announcement.
FINDEX Inc. has been contracted by MEDIS to manage the paid introduction of electronic signatures for prescriptions using the HPKI Second Electronic Certificate starting April 2025. This move aligns with the Japanese government’s policy to digitize healthcare documentation, aiming to replace traditional paper prescriptions with electronic ones across medical facilities. The company will handle administrative duties including service applications and payment collections nationwide, currently serving approximately 10,000 registered users. While the financial impact remains uncertain, this development positions FINDEX as a key player in the digitization of Japan’s healthcare sector.
More about FINDEX Inc.
FINDEX Inc. operates in the electronic prescription and healthcare technology industry, specializing in remote electronic signature services essential for the digital management of prescriptions and dispensing registrations. The company focuses on integrating cloud-based solutions to streamline medical processes across hospitals, clinics, and pharmacies in Japan.
YTD Price Performance: 4.44%
Average Trading Volume: 44,088
Technical Sentiment Consensus Rating: Sell
Current Market Cap: Yen22.9B
Learn more about 3649 stock on TipRanks’ Stock Analysis page.